Our Strategy
To unlock and maximize the potential of Psychedelic based medicines, for people suffering from pain, addiction, and mental health disorders and make a positive impact on the communities we serve.
Shields Pharma Inc. primary focus is on the research and development, formulation, and scientific laboratory analysis of psychedelic drugs including, Psilocybin, Psilocin, MDMA (methylenedioxyamphetamine), DMT (Dimethyltryptamine) Ketamine, LSD (Lysergic acid diethylamide) and other controlled substances and drugs.
Our key activities include the cultivation of Psilocybe Cubensis mushrooms (magic mushrooms), extraction of Psilocybin and other psychoactive compounds, the development of proprietary processes and products, standardizing analytical methods for psychedelics and the development of a pipeline for product development and protocol development for safety and efficacy studies.
Shields Pharma also focuses on providing contract testing services to the pharmaceutical, nutraceutical and cosmetic industries. Our testing services provide dependable analytical testing for active pharmaceutical ingredients (APIs), excipients and finished products performed under our fully traceable and accountable cGMP systems.
Shields Pharma provides comprehensive analytical testing services for controlled substances and other active ingredients, excipients and finished products. We have implemented comprehensive Quality Control Policies and Management Systems, ensuring compliance with Health Canada regulations under cGMP and GPP, and the US FDA guidelines.
Shields Pharma offers and promotes analytical testing services to provide a Certificate of Analysis (CoA) to 3rd parties who are looking to have their products tested prior to distribution to the market using a variety of instrumental and chemical techniques to fulfill all regulatory and compendial testing requirements for the Pharmaceutical, Nutraceutical and Cosmetic industries.
Shields Pharma is fully compliant with current Good Manufacturing Practices (cGMP) as defined by all regulatory bodies. This compliant testing is used to verify the quality of a raw material (excipient or API) used in a finished product destined for market and to justify the use of the finished product itself.
Additionally, method development, method validation, method transfer and method verification are conducted, in coordination with the client, to ensure the method performs as expected to deliver dependable results every time it is applied.